Clinical Trial Update: Objective Evaluation of Intradermal MSC-Derived Exosome Therapy on Facial Skin Quality [Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 3 study evaluating intradermal mesenchymal stem cell-derived exosome therapy for improving facial skin quality in agi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Aging
• Skin Aging

Drugs mentioned

• MSC-derived exosome therapy (intradermal)

Snippet

Sponsor: Mert Ersan | Conditions: Skin Aging, Facial Aging | Phase 3 | Status: NOT_YET_RECRUITING